Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization

Exogenous human follicle-stimulating hormone (hFSH), either derived from extraction and purification from the urine or obtained by recombinant technology in the form of follitropin <i>α</i>, <i>β</i> and <i>δ</i> (rFSH), has been used for decades in the treatment...

Full description

Bibliographic Details
Main Authors: Loredana Bergandi, Stefano Canosa, Andrea Roberto Carosso, Carlotta Paschero, Gianluca Gennarelli, Francesca Silvagno, Chiara Benedetto, Alberto Revelli
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Pharmaceuticals
Subjects:
recombinant human follicle-stimulating hormone (r-hFSH)
r-hFSH biosimilars
controlled ovarian stimulation
in vitro fertilization
Online Access:https://www.mdpi.com/1424-8247/13/7/136

Internet

https://www.mdpi.com/1424-8247/13/7/136

Similar Items